LEADER 00753nam0 2200265   450 
001 9910303657103321
005 20200113153058.0
010   $a978-0-323-58116-5
100   $a20190117d2019----km y0itay50      ba
101 0 $aeng
102   $aUS
105   $a        001yy
200 1 $aPharmacovigilance$ea practical approach$fThao Doan ... [et al.]
210   $aSt. Louis$cElselvier$d2019
215   $axiii, 213 p.$d24 cm
702  1$aDoan,$bThao
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910303657103321
952   $a80 SP XIV D 48$bBFA49/2019$fFFABC
952   $a80 XIV D 49$bBFA50/2019$fFFABC
952   $a80 XIV D 50$bBFA51/2019$fFFABC
959   $aFFABC
996   $aPharmacovigilance$91541941
997   $aUNINA